Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Expert Opinion on Biological Therapy|February 26, 2008
Oligosaccharides as anti-angiogenic agentsClaire Louise Cole, Gordon C Jayson
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 9, 2005
Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeuticsRuth Board, Gordon C Jayson
The Oncologist|February 15, 2005
Molecular imaging of antiangiogenic agentsShazza Rehman, Gordon C Jayson
Current Opinion in Oncology|August 15, 2013
Angiogenesis as a target for the treatment of ovarian cancerDanielle Shaw, Andrew Clamp, Gordon C Jayson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Do imaging biomarkers relate to outcome in patients treated with VEGF inhibitors?James P B O'Connor, Gordon C Jayson
Expert Opinion on Drug Metabolism & Toxicology|January 31, 2012
Is the toxicity of anti-angiogenic drugs predictive of outcome? A review of hypertension and proteinuria as biomarkers of response to anti-angiogenic therapyLaura Horsley, Kalena Marti, Gordon C Jayson
Expert Opinion on Therapeutic Targets|November 16, 2006
A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesisSofia Baka, Andrew R Clamp, Gordon C Jayson
Nature Reviews. Clinical Oncology|February 15, 2012
Antiangiogenic therapy--evolving view based on clinical trial resultsGordon C Jayson, Daniel J Hicklin, Lee M Ellis
BMC Nephrology|October 24, 2019
Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort studyRajkumar Chinnadurai, Emma Flanagan, Gordon C Jayson, et al.
The Journal of Biological Chemistry|February 25, 2014
Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signalingClaire L Cole, Graham Rushton, Gordon C Jayson, et al.
Pageof 12